CART Cell Toxicities: New Insight into Mechanisms and Management.

Clin Hematol Int · 2020 · PMC7785104 · PMID 33409484

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

This is the framework most commonly used to develop CART cells, but there may be significant variations in manufacturing techniques. 2.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.